Jonathan D. Marmur, MD, FACC

Feature

Direct Versus Indirect Thrombin Inhibition in Percutaneous Coronary Intervention (Part II)

08/01/2008

Continued from previous page Randomized trials. A retrospective analysis of randomized studies supports the findings of the case-control studies. In 1,863 heparin-treated patients, there was an inverse relation between the ACT values...

Continued from previous...

08/01/2008

Journal of Invasive Cardiology

Clinical Images

Coronary Air Embolization in the Left Coronary Artery

08/01/2008

Spyros Kokolis , MD;

Alan Feit , MD;

Jonathan D. Marmur , MD, FACC;

Coronary air embolism is a recognized complication of cardiac catheterization occurring in 0.1–0.3% of cases.1 Sequelae range from various clinically-insignificant events to an acute coronary syndrome and death.2 The possible mechanisms of...

Coronary air embolism is a...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

High-Dose Tirofiban Administered as Bolus-Only during
Percutaneous Coronary Intervention

08/01/2008

Nagarathna Manjappa , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Shyam Poludasu , MD;

Ajay Agarwal , MD;

Inhibition of platelet glycoprotein IIb/IIIa receptors during percutaneous coronary intervention (PCI) using tirofiban, eptifibatide and abciximab has been associated with improved outcomes.1 The only head-to-head comparison to these agents...

Inhibition of platelet...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Impact of Gender on In-Hospital Percutaneous Coronary Interventional Outcomes in African-Americans

08/01/2008

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Luther T. Clark , MD;

Shyam Poludasu , MD;

Multiple studies have demonstrated that women are at increased risk for in-hospital mortality, stroke, vascular complications, repeat revascularization, and same-admission coronary artery bypass graft surgery (CABG) after percutaneous...

Multiple studies have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Bolus-Only Platelet Glycoprotein IIb/IIIa Inhibition During Percutaneous Coronary Intervention

08/01/2008

Reuven Lapin , PA-C, PA;

Shyam Poludasu , MD;

Jonathan D. Marmur , MD, FACC;

Erdal Cavusoglu , MD;

Pompeiu Vladutiu , MD;

Ajay Agarwal , MD;

Alan Feit , MD;

Several large randomized clinical trials and meta-analyses have shown that inhibition of platelet aggregation with platelet glycoprotein IIb/IIIa inhibitors (GPI) improves outcomes in patients presenting with acute coronary syndromes and in...

Several large randomized...

08/01/2008

Journal of Invasive Cardiology